mRNA as novel technology for passive immunotherapy | SpringerLink
RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease | Molecular Pharmacology
mRNA as novel technology for passive immunotherapy | SpringerLink
Frontiers | Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies | Immunology
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization | Nature Biotechnology
mRNA as novel technology for passive immunotherapy | SpringerLink
Frontiers | Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties | Chemistry
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect
PDF) Techniques to Study Antigen-Specific B Cell Responses
Frontiers | IgG Subclass Determines Suppression Versus Enhancement of Humoral Alloimmunity to Kell RBC Antigens in Mice | Immunology
Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews Immunology
Cancer systems immunology | eLife
PDF) Therapeutic antibodies for autoimmunity and inflammation
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning | Nature Reviews Immunology
Targeting cytokines in disease | Nature Immunology
Frontiers | Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells | Immunology
Post‐transcriptional control of immune responses and its potential application - Yoshinaga - 2019 - Clinical & Translational Immunology - Wiley Online Library
Frontiers | Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance | Immunology
Frontiers | Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer | Immunology
